Prevention of late postmyocardial infarction left ventricular remodeling: An update

Current Heart Failure Reports

Volumn 6, Issue 4, 2009, Pages 245-253

  Mookadam, Farouk ^a   Moustafa, Sherif E ^b  

^a MAYO CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE REMODELING; HUMAN; MITRAL VALVE; OPEN HEART SURGERY; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PREVENTION STUDY; REVASCULARIZATION; REVIEW; STEM CELL TRANSPLANTATION; SURGICAL TECHNIQUE;

CARDIOTONIC AGENTS; ELECTRIC COUNTERSHOCK; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 72449180551     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-009-0034-4     Document Type: Review

References (75)

1. N. Sharpe 2004 Pharmacologic effects on cardiac remodeling Curr Heart Fail Rep 1 9 13 10.1007/s11897-004-0011-x 16036019
2. M.A. Pfeffer E. Braunwald 1990 Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications Circulation 81 1161 1172 1:STN:280:DyaK3c3gtVWjsQ%3D%3D 2138525
3. J.N. Cohn R. Ferrari N. Sharpe 2000 Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 569 582 10.1016/S0735-1097(99)00630-0 1:STN:280: DC%2BD3c7nvFajsw%3D%3D 10716457 (Pubitemid 30167013)
4. U. Landmesser K.C. Wollert H. Drexler 2009 Potential novel pharmacological therapies for myocardial remodelling Cardiovasc Res 81 519 527 10.1093/cvr/cvn317 1:CAS:528:DC%2BD1MXhtlKitLY%3D 19019834
5. S.D. Solomon R.J. Glynn S. Greaves, et al. 2001 Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study Ann Intern Med 134 451 458 1:STN:280:DC%2BD3M7mt1KlsA%3D%3D 11255520
6. M. St. John Sutton D. Lee J.L. Rouleau, et al. 2003 Left ventricular remodeling and ventricular arrhythmias after myocardial infarction Circulation 107 2577 2582 10.1161/01.CIR.0000065226.24159.E9 12732606 (Pubitemid 36506071)
7. S.R. Tiyyagura S.P. Pinney 2006 Left ventricular remodeling after myocardial infarction: past, present, and future Mt Sinai J Med 73 840 851 17117309
8. J.M. Pfeffer M.A. Pfeffer P.J. Fletcher E. Braunwald 1991 Progressive ventricular remodeling in rat with myocardial infarction Am J Physiol 260 H1406 H1414 1:STN:280:DyaK3M3ktFehsQ%3D%3D 2035662
9. H.F. Weisman D.E. Bush J.A. Mannisi, et al. 1988 Cellular mechanisms of myocardial infarct expansion Circulation 78 186 201 1:STN:280: DyaL1c3ltlOluw%3D%3D 2968197
10. G.F. Mitchell G.A. Lamas D.E. Vaughan M.A. Pfeffer 1992 Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape J Am Coll Cardiol 19 1136 1144 1:STN:280:DyaK383is1elsQ%3D%3D 1532970
11. G.F. Mitchell G.A. Lamas M.A. Pfeffer 1993 Ventricular remodeling after myocardial infarction Adv Exp Med Biol 346 265 276 1:STN:280: DyaK2c3ktFSrsg%3D%3D 8184764
12. Y.C. Fu C.S. Chi S.C. Yin, et al. 2004 Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species-TNF alpha-caspase signaling pathway Cardiovasc Res 62 558 567 10.1016/j.cardiores. 2004.01.039 1:CAS:528:DC%2BD2cXkt1SktLg%3D 15158148 (Pubitemid 38648970)
13. B.I. Jugdutt J.W. Warnica 1988 Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location Circulation 78 906 919 1:STN:280: DyaL1M%2FgtlGjtA%3D%3D 3139326
14. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together withdrawn six weeks after acute myocardial infarction: the GISSI-3 trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. J Am Coll Cardiol 1996, 27:337-344.
15. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. Lancet 1995, 345:669-685.
16. The SOLVD Investigators 1991 Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure N Engl J Med 325 293 302
17. M.A. Pfeffer E. Braunwald L.A. Moy, et al. 1992 Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial N Engl J Med 327 669 677 1:STN:280:DyaK38zlslSrtQ%3D%3D 1386652
18. L. Køber C. Torp-Pedersen J.E. Carlsen, et al. 1995 A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 333 1670 1676 10.1056/NEJM199512213332503 7477219 (Pubitemid 26001955)
19. M.A. Pfeffer K. Swedberg C.B. Granger, et al. 2003 Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 759 766 10.1016/S0140-6736(03)14282-1 1:CAS:528:DC%2BD3sXntVGktL0%3D 13678868 (Pubitemid 37093915)
20. W.T. Abraham B.H. Greenberg C.W. Yancy 2008 Pharmacologic therapies across the continuum of left ventricular dysfunction Am J Cardiol 102 21G 28G 10.1016/j.amjcard.2008.06.007 1:CAS:528:DC%2BD1cXhtVeis77L 18722188
21. J.N. Cohn G. Tognoni 2001 A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure N Engl J Med 345 1667 1675 10.1056/NEJMoa010713 1:CAS:528:DC%2BD3MXovFKjtLc%3D 11759645 (Pubitemid 33126822)
22. S.A. Hunt 2005 ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 46 e1 e82 10.1016/j.jacc.2005.08.022 16168273 (Pubitemid 41316530)
23. K. Dickstein J. Kjekshus 2002 Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial Lancet 360 752 760 10.1016/S0140-6736(02)09895-1 1:CAS:528:DC%2BD38Xmsl2nsLs%3D 12241832 (Pubitemid 35247704)
24. M.A. Pfeffer J.J. McMurray E.J. Velazquez, et al. 2003 Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both N Engl J Med 349 1893 1906 10.1056/NEJMoa032292 1:CAS:528:DC%2BD3sXptVGnuro%3D 14610160 (Pubitemid 37409706)
25. MERIT-HF Study Group 1999 Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERITHF) Lancet 353 2001 2007 10.1016/S0140-6736(99)04440-2 (Pubitemid 29271744)
26. The CIBIS-II Investigators 1999 The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 9 13 10.1016/S0140-6736(98) 11181-9 (Pubitemid 29037695)
27. The CAPRICORN Investigators 2001 Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 1385 1390 10.1016/S0140-6736(00)04560-8 (Pubitemid 32455364)
28. M. Packer A.J.S. Coats M.B. Fowler, et al. 2001 Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 1651 1658 10.1056/NEJM200105313442201 1:CAS:528:DC%2BD3MXkslWjt7c%3D 11386263 (Pubitemid 32479962)
29. B. Pitt F. Zannad W.J. Remme, et al. 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure N Engl J Med 341 709 717 10.1056/NEJM199909023411001 1:CAS:528:DyaK1MXmtVyrurk%3D 10471456 (Pubitemid 29407370)
30. B. Pitt W. Remme F. Zannad, et al. 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 1309 132 10.1056/NEJMoa030207 1:CAS:528:DC%2BD3sXis1ehurY%3D 12668699 (Pubitemid 36384098)
31. M. Scherrer-Crosbie R. Ullrich K.D. Bloch, et al. 2001 Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice Circulation 104 1286 1291 10.1161/hc3601.094298 1:CAS:528: DC%2BD3MXnsV2mtL4%3D 11551881
32. P.B. Massion J.L. Balligand 2007 Relevance of nitric oxide for myocardial remodeling Curr Heart Fail Rep 4 18 25 10.1007/s11897-007-0021-6 1:CAS:528:DC%2BD2sXpslekur4%3D 17386181
33. L. Timmers J.P. Sluijter J.K. van Keulen, et al. 2008 Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction Circ Res 102 257 264 10.1161/CIRCRESAHA.107.158220 1:CAS:528:DC%2BD1cXhtVGkur8%3D 18007026 (Pubitemid 351674064)
34. A. Abbate F.N. Salloum E. Vecile, et al. 2008 Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction Circulation 117 2670 2683 10.1161/CIRCULATIONAHA. 107.740233 1:CAS:528:DC%2BD1cXlvVCntrs%3D 18474815
35. D. Kelly G. Cockerill L.L. Ng, et al. 2007 Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study Eur Heart J 28 711 718 10.1093/eurheartj/ehm003 1:CAS:528:DC%2BD2sXlt1Ojt7w%3D 17339265 (Pubitemid 46439245)
36. GUSTO 1993 Comparison of four therapeutic strategies in acute myocardial infarction. Washington, 30 April 1993 [in German] Internist (Berl) 34 7Suppl 1 12
37. O.A. Centurión 2007 The open artery hypothesis: beneficial effects and long-term prognostic importance of patency of the infarct-related coronary artery Angiology 58 34 44 10.1177/0003319706295212 17351156 (Pubitemid 46272183)
38. J.W. Kennedy J.L. Ritchie K.B. Davis, et al. 1985 The Western Washington Randomized Trial of intracoronary streptokinase in acute myocardial infarction: a 12-months follow-up report N Engl J Med 312 1073 1078 1:STN:280: DyaL2M7mtlKhsA%3D%3D 3982468
39. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Lancet 1988, 2:349-360.
40. V. Dzavik D.S. Beanlands R.F. Davies, et al. 1994 Effects of late percutaneous transluminal coronary angioplasty of an occluded infarct-related coronary artery on left ventricular function in patients with a recent (< 6 weeks) Q-wave acute myocardial infarction (Total Occlusion Post-Myocardial Infarction Interventional Study [TOMIIS]-a pilot study) Am J Cardiol 73 856 861 10.1016/0002-9149(94)90809-5 1:STN:280:DyaK2c3ktFWhtA%3D%3D 8184807
41. P.G. Steg C. Thuaire D. Himbert, et al. 2004 DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction Eur Heart J 25 2187 2194 10.1016/j.ehj.2004.10.019 15589635 (Pubitemid 39592419)
42. V. Dzavik C.E. Buller G.A. Lamas, et al. 2006 Randomized trial of percutaneous coronary intervention for subacute infarctrelated coronary artery occlusion to achieve long-term patency and improve ventricular function. The Total Occlusion Study of Canada (TOSCA)-2 Trial Circulation 114 2449 2457 10.1161/CIRCULATIONAHA.106.669432 17105848 (Pubitemid 44901517)
43. J.S. Hochman G.A. Lamas C.E. Buller, et al. 2006 Coronary intervention for persistent occlusion after myocardial infarction N Engl J Med 355 2395 2407 10.1056/NEJMoa066139 1:CAS:528:DC%2BD28Xht12ntr%2FF 17105759 (Pubitemid 44911017)
44. D.L. Appleton A. Abbate G.G. Biondi-Zoccai 2008 Late percutaneous coronary intervention for the totally occluded infarct-related artery: a meta-analysis of the effects on cardiac function and remodeling Catheter Cardiovasc Interv 71 772 781 10.1002/ccd.21468 18415952 (Pubitemid 351681634)
45. M. Leacche J.M. Balaguer J.G. Byrne 2008 Role of cardiac surgery in the post-myocardial infarction patient with heart failure Curr Heart Fail Rep 5 204 210 10.1007/s11897-008-0031-z 19032915
46. E.L. Alderman M.G. Bourassa L.S. Cohen, et al. 1990 Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study Circulation 82 1629 1646 1:STN:280:DyaK3M%2FivFyqug%3D%3D 2225367
47. S. Yusuf D. Zucker P. Peduzzi, et al. 1994 Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration Lancet 344 563 570 10.1016/S0140-6736(94)91963-1 1:STN:280:DyaK2czktl2guw%3D%3D 7914958 (Pubitemid 24267213)
48. R.H. Jones E.J. Velazquez R.E. Michler, et al. 2009 Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 1705 1717 10.1056/NEJMoa0900559 1:CAS:528:DC%2BD1MXkvVOmsbc%3D 19329820
49. K.C. Allman L.J. Shaw R. Hachamovitch J.E. Udelson 2002 Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis J Am Coll Cardiol 39 1151 1158 10.1016/S0735-1097(02)01726-6 11923039 (Pubitemid 34267418)
50. J. Elefteriades R. Edwards 2002 Coronary bypass in left heart failure Semin Thorac Cardiovasc Surg 14 125 132 10.1053/stcs.2002.32321 11988950
51. M.A. Borger A. Alam P.M. Murphy, et al. 2006 Chronic ischemic mitral regurgitation: repair, replace or rethink? Ann Thorac Surg 81 1153 1161 10.1016/j.athoracsur.2005.08.080 16488757 (Pubitemid 43247724)
52. E.A. Grossi J.D. Goldberg A. LaPietra, et al. 2001 Ischemic mitral valve reconstruction and replacement: comparison of longterm survival and complications J Thorac Cardiovasc Surg 122 1107 1124 10.1067/mtc.2001.116945 1:STN:280:DC%2BD3MnotVGluw%3D%3D 11726886
53. V. Badhwar S.F. Bolling 2002 Mitral valve surgery in the patient with left ventricular dysfunction Semin Thorac Cardiovasc Surg 14 133 136 10.1053/stcs.2002.32314 11988951
54. J.J. Bax J. Braun S.T. Somer, et al. 2004 Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling Circulation 110 11Suppl1 II103 II108 15364847
55. A. Parolari M. Naliato C. Loardi, et al. 2007 Surgery of left ventricular aneurysm: a meta analysis of early outcomes following different reconstruction techniques Ann Thorac Surg 83 2009 2016 10.1016/j.athoracsur.2007.01.032 17532388 (Pubitemid 46782651)
56. L. Menicanti S. Castelvecchio M. Ranucci, et al. 2007 Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration J Thorac Cardiovasc Surg 134 433 441 10.1016/j.jtcvs.2006.12.027 17662785 (Pubitemid 47088562)
57. V. Dor M. Sabatier F. Montiglio, et al. 2004 Endoventricular patch reconstruction of ischemic failing ventricle: a single center with 20 years experience. Advantages of magnetic resonance imaging assessment Heart Fail Rev 9 269 286 10.1007/s10741-005-6804-5 1:STN:280:DC%2BD2M3kslSjtw%3D%3D 15886973
58. C.L. Athanasuleas G.D. Buckberg A.W. Stanley, et al. 2004 Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation J Am Coll Cardiol 44 1439 1445 10.1016/j.jacc.2004.07.017 15464325 (Pubitemid 39303946)
59. T.S. Maxey T.B. Reece P.I. Ellman, et al. 2004 Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy J Thorac Cardiovasc Surg 127 428 434 10.1016/j.jtcvs.2003.09.024 14762351 (Pubitemid 38176647)
60. M.A. Acker S. Bolling R. Shemin, et al. 2006 Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial J Thorac Cardiovasc Surg 132 568 577 10.1016/j.jtcvs.2006.02.062 16935112 (Pubitemid 44278906)
61. H.W. Rahmouni J.N. Kirkpatrick M.G. St John Sutton 2008 Effects of cardiac resynchronization therapy on ventricular remodeling Curr Heart Fail Rep 5 25 30 10.1007/s11897-008-0005-1 18460291
62. J.G. Cleland J.C. Daubert E. Erdmann, et al. 2005 Baseline characteristics of patients recruited into the CARE-HF study Eur J Heart Fail 7 205 214 10.1016/j.ejheart.2005.01.010 1:STN:280:DC%2BD2M%2Fnt1CjtQ%3D%3D 15701468 (Pubitemid 40215614)
63. S.A. Mollema S.S. Liem M.S. Suffoletto, et al. 2007 Left ventricular dyssynchrony acutely after myocardial infarction predicts left ventricular remodeling Am Coll Cardiol 50 1532 1540 10.1016/j.jacc.2007.07.025 (Pubitemid 47532333)
64. Y. Zhang G.W. Yip A.K. Chan, et al. 2008 Left ventricular systolic dyssynchrony is a predictor of cardiac remodeling after myocardial infarction Am Heart J 156 1124 1132 10.1016/j.ahj.2008.07.019 19033008
65. G.P. Meyer K.C. Wollert H. Drexler 2007 The role of stem cells in the post-MI patient Curr Heart Fail Rep 4 198 203 10.1007/s11897-007-0013-6 18221616
66. K.C. Wollert G.P. Meyer J. Lotz, et al. 2004 Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial Lancet 364 141 148 10.1016/S0140-6736(04)16626-9 15246726 (Pubitemid 38891685)
67. V. Schachinger S. Erbs A. Elsasser, et al. 2006 Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction N Engl J Med 355 1210 1221 10.1056/NEJMoa060186 1:CAS:528:DC%2BD28XpvFKgs70%3D 16990384 (Pubitemid 44427445)
68. S. Janssens C. Dubois J. Bogaert, et al. 2006 Autologous bone marrow-derived stem-cell transfer in patients with ST segment elevation myocardial infarction: double-blind, randomised controlled trial Lancet 367 113 121 10.1016/S0140-6736(05)67861-0 16413875 (Pubitemid 43077127)
69. K. Lunde S. Solheim S. Aakhus, et al. 2006 Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction N Engl J Med 355 1199 1209 10.1056/NEJMoa055706 1:CAS:528:DC%2BD28XpvFKgsr0%3D 16990383 (Pubitemid 44427444)
70. A. Schaefer G.P. Meyer M. Fuchs, et al. 2006 Impact of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: results from the BOOST trial Eur Heart J 27 929 935 10.1093/eurheartj/ehi817 16510465
71. V. Schachinger B. Assmus M.B. Britten, et al. 2004 Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial J Am Coll Cardiol 44 1690 1699 10.1016/j.jacc.2004.08.014 15489105 (Pubitemid 39369805)
72. B. Assmus J. Honold V. Schachinger, et al. 2006 Transcoronary transplantation of progenitor cells after myocardial infarction N Engl J Med 355 1222 1232 10.1056/NEJMoa051779 1:CAS:528:DC%2BD28XpvFKgsb8%3D 16990385 (Pubitemid 44427446)
73. H. Ince M. Petzsch H.D. Kleine, et al. 2005 Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI) Circulation 112 3097 3106 10.1161/CIRCULATIONAHA.105.541433 1:CAS:528:DC%2BD2MXhtF2rtbbF 16275869 (Pubitemid 43113441)
74. C.M. Yu C.B. Bleeker J.W.H. Fung, et al. 2005 Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronisation therapy Circulation 112 1580 1586 10.1161/ CIRCULATIONAHA.105.538272 16144994 (Pubitemid 41324519)
75. S. Funaro G. La Torre M. Madonna, et al. 2009 Incidence, determinants, and prognostic value of reverse left ventricular remodelling after primary percutaneous coronary intervention: results of the Acute Myocardial Infarction Contrast Imaging (AMICI) multicenter study Eur Heart J 30 566 575 10.1093/eurheartj/ehn529 19098019